News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,432 Results
Type
Article (39743)
Company Profile (247)
Press Release (660442)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204193)
Career Advice (2008)
Deals (35423)
Drug Delivery (95)
Drug Development (81053)
Employer Resources (172)
FDA (16189)
Job Trends (14864)
News (345235)
Policy (32547)
Tag
Academia (2555)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49448)
ALS (96)
Alzheimer's disease (1387)
Antibody-drug conjugate (ADC) (133)
Approvals (16187)
Artificial intelligence (265)
Autoimmune disease (22)
Automation (17)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (175)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (293)
Cancer (2337)
Cardiovascular disease (181)
Career advice (1677)
Career pathing (30)
CAR-T (160)
Cell therapy (445)
Cervical cancer (20)
Clinical research (66124)
Collaboration (864)
Company closure (2)
Compensation (574)
Complete response letters (19)
COVID-19 (2590)
CRISPR (41)
C-suite (252)
Cystic fibrosis (102)
Data (2379)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (278)
Diagnostics (6389)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (105)
Drug shortages (25)
Duchenne muscular dystrophy (99)
Earnings (87230)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (112749)
Executive appointments (747)
FDA (17588)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (780)
Gene editing (109)
Generative AI (20)
Gene therapy (321)
GLP-1 (723)
Government (4432)
Grass and pollen (4)
Guidances (174)
Healthcare (18821)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (126)
Indications (29)
Infectious disease (2735)
Inflammatory bowel disease (143)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (99)
Interviews (312)
IPO (16531)
IRA (40)
Job creations (3633)
Job search strategy (1422)
Kidney cancer (10)
Labor market (43)
Layoffs (475)
Leadership (17)
Legal (7911)
Liver cancer (76)
Lung cancer (327)
Lymphoma (163)
Machine learning (9)
Management (58)
Manufacturing (330)
MASH (79)
Medical device (13389)
Medtech (13394)
Mergers & acquisitions (19476)
Metabolic disorders (717)
Multiple sclerosis (85)
NASH (16)
Neurodegenerative disease (97)
Neuropsychiatric disorders (28)
Neuroscience (1957)
NextGen: Class of 2025 (6512)
Non-profit (4481)
Now hiring (40)
Obesity (376)
Opinion (205)
Ovarian cancer (81)
Pain (91)
Pancreatic cancer (88)
Parkinson's disease (156)
Partnered (22)
Patents (247)
Patient recruitment (117)
Peanut (46)
People (57364)
Pharmaceutical (63)
Pharmacy benefit managers (20)
Phase I (20609)
Phase II (29131)
Phase III (21677)
Pipeline (1452)
Policy (147)
Postmarket research (2563)
Preclinical (8769)
Press Release (64)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (389)
Real estate (5908)
Recruiting (65)
Regulatory (22335)
Reports (48)
Research institute (2321)
Resumes & cover letters (349)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (72)
Series A (135)
Series B (91)
Service/supplier (11)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3580)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (51)
The Weekly (30)
Vaccines (700)
Venture capitalists (42)
Weight loss (237)
Women's health (36)
Worklife (16)
Date
Today (206)
Last 7 days (944)
Last 30 days (3448)
Last 365 days (32515)
2025 (12328)
2024 (35218)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46539)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (55)
Alaska (7)
Arizona (234)
Arkansas (13)
Asia (37891)
Australia (6196)
California (6539)
Canada (2088)
China (539)
Colorado (278)
Connecticut (284)
Delaware (159)
Europe (81464)
Florida (970)
Georgia (219)
Idaho (57)
Illinois (553)
India (25)
Indiana (324)
Iowa (11)
Japan (176)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (63)
Maryland (931)
Massachusetts (4844)
Michigan (227)
Minnesota (408)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (69)
New Hampshire (63)
New Jersey (1816)
New Mexico (28)
New York (1832)
North Carolina (997)
North Dakota (8)
Northern California (2895)
Ohio (212)
Oklahoma (14)
Oregon (34)
Pennsylvania (1443)
Puerto Rico (13)
Rhode Island (33)
South America (1097)
South Carolina (27)
South Dakota (1)
Southern California (2455)
Tennessee (108)
Texas (968)
United States (24383)
Utah (191)
Virginia (154)
Washington D.C. (64)
Washington State (570)
West Virginia (3)
Wisconsin (58)
700,432 Results for "veracyte inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veracyte Announces First Quarter 2025 Financial Results
May 8, 2025
·
19 min read
Press Releases
Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
April 28, 2025
·
6 min read
Press Releases
Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025
April 17, 2025
·
1 min read
Press Releases
New Data Demonstrate Accuracy of Veracyte’s Whole-Genome Sequencing-Based MRD Testing Platform for Muscle-Invasive Bladder Cancer
March 25, 2025
·
7 min read
Press Releases
New Study Shows Veracyte’s Decipher Bladder Test Predicts Disease Upstaging in Patients with Bladder Cancer
February 5, 2025
·
7 min read
Press Releases
Veracyte Announces Fourth Quarter and Full Year 2024 Financial Results
February 24, 2025
·
20 min read
Press Releases
Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting
April 22, 2025
·
8 min read
Press Releases
Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
April 21, 2025
·
4 min read
Biotech Bay
Veracyte to Participate in Upcoming Investor Conferences - May 15, 2024
Veracyte, Inc. a leading cancer diagnostics company, announced it will participate in the following investor conferences.
May 15, 2024
·
1 min read
Press Releases
New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research
February 17, 2025
·
10 min read
1 of 70,044
Next
